AAAAAA

   
Results: 1-14 |
Results: 14
EVALUATION OF A NEW AUTOMATED ELISA TEST FOR VON-WILLEBRAND-FACTOR USING 2 MONOCLONAL-ANTIBODIES
Authors: PITTET JL BARBALAT V SANVERT M VILLARD C JORIEUX S MAZURIER C
Citation: Jl. Pittet et al., EVALUATION OF A NEW AUTOMATED ELISA TEST FOR VON-WILLEBRAND-FACTOR USING 2 MONOCLONAL-ANTIBODIES, Blood coagulation & fibrinolysis, 8(4), 1997, pp. 209-215
MUTATIONS ON CYSTEINE RESIDUE-25 AND RESIDUE-95 OF MATURE VON-WILLEBRAND-FACTOR INDUCE TYPE 2N VON-WILLEBRAND-DISEASE
Authors: JORIEUX S GAUCHER C FRESSINAUD E GOUDEMAND J MEYER D MAZURIER C
Citation: S. Jorieux et al., MUTATIONS ON CYSTEINE RESIDUE-25 AND RESIDUE-95 OF MATURE VON-WILLEBRAND-FACTOR INDUCE TYPE 2N VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 1586-1586
CHARACTERIZATION OF ARG527 AND ARG531 SUBSTITUTION VARIANTS OF FACTOR-VIII ASSOCIATED WITH MILD HEMOPHILIA-A
Authors: CELIE PHN DONATH MJSH JORIEUX S VANMOURIK JA MAZURIER C MERTENS K
Citation: Phn. Celie et al., CHARACTERIZATION OF ARG527 AND ARG531 SUBSTITUTION VARIANTS OF FACTOR-VIII ASSOCIATED WITH MILD HEMOPHILIA-A, Thrombosis and haemostasis, 1997, pp. 2333-2333
A NEW AUTOMATED ELISA TEST FOR VON-WILLEBRAND-FACTOR USING 2 MONOCLONAL-ANTIBODIES
Authors: PITTET JL BARBALAT V SANVERT M VILLARD C JORIEUX S
Citation: Jl. Pittet et al., A NEW AUTOMATED ELISA TEST FOR VON-WILLEBRAND-FACTOR USING 2 MONOCLONAL-ANTIBODIES, Thrombosis and haemostasis, 1997, pp. 2575-2575
NEW MUTATIONS OF VON-WILLEBRAND-FACTOR (Y271TER AND G785E (GLY22GLU))IN A COMPOUND HETEROZYGOUS PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE
Authors: LAVERGNE JM GU J JORIEUX S RASTEGARLARI G RUAN C MAZURIER C MEYER D
Citation: Jm. Lavergne et al., NEW MUTATIONS OF VON-WILLEBRAND-FACTOR (Y271TER AND G785E (GLY22GLU))IN A COMPOUND HETEROZYGOUS PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2666-2666
A NEW MUTATION, CYS-]ARG AT POSITION-297 OF MATURE VON-WILLEBRAND-FACTOR (VWF), IS IDENTIFIED IN SEVERAL PATIENTS WITH DECREASED FACTOR-VIII BINDING-CAPACITY OF VWF
Authors: JORIEUX S GAUCHER C PARQUET A GOUDEMAND J MAZURIER C
Citation: S. Jorieux et al., A NEW MUTATION, CYS-]ARG AT POSITION-297 OF MATURE VON-WILLEBRAND-FACTOR (VWF), IS IDENTIFIED IN SEVERAL PATIENTS WITH DECREASED FACTOR-VIII BINDING-CAPACITY OF VWF, Thrombosis and haemostasis, 1997, pp. 2668-2668
GENE DEFECTS IN 150 UNRELATED FRENCH CASES WITH TYPE-2 VON-WILLEBRAND-DISEASE - FROM THE PATIENT TO THE GENE
Authors: MEYER D FRESSINAUD E GAUCHER C LAVERGNE JM HILBERT L RIBBA AS JORIEUX S MAZURIER C
Citation: D. Meyer et al., GENE DEFECTS IN 150 UNRELATED FRENCH CASES WITH TYPE-2 VON-WILLEBRAND-DISEASE - FROM THE PATIENT TO THE GENE, Thrombosis and haemostasis, 78(1), 1997, pp. 451-456
MUTATIONS IN THE FVIII GENE IN 7 FAMILIES WITH MILD HEMOPHILIA-A
Authors: MAZURIER C GAUCHER C JORIEUX S PARQUETGERNEZ A
Citation: C. Mazurier et al., MUTATIONS IN THE FVIII GENE IN 7 FAMILIES WITH MILD HEMOPHILIA-A, British Journal of Haematology, 96(2), 1997, pp. 426-427
PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE IS HETEROZYGOUS FOR A NEWMUTATION - GLY22GLU - DEMONSTRATION OF A DEFECTIVE EXPRESSION OF THE 2ND ALLELE BY THE USE OF MONOCLONAL-ANTIBODIES
Authors: GU J JORIEUX S LAVERGNE JM RUAN C MAZURIER C MEYER D
Citation: J. Gu et al., PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE IS HETEROZYGOUS FOR A NEWMUTATION - GLY22GLU - DEMONSTRATION OF A DEFECTIVE EXPRESSION OF THE 2ND ALLELE BY THE USE OF MONOCLONAL-ANTIBODIES, Blood, 89(9), 1997, pp. 3263-3269
NEW MUTATION OF VON-WILLEBRAND-FACTOR (GLY22GLU) IN A PATIENT OF CHINESE ORIGIN WITH TYPE 2N VON-WILLEBRAND DISEASE
Authors: GU J JORIEUX S LAVERGNE JM RUAN C MAZURIER C MEYER D
Citation: J. Gu et al., NEW MUTATION OF VON-WILLEBRAND-FACTOR (GLY22GLU) IN A PATIENT OF CHINESE ORIGIN WITH TYPE 2N VON-WILLEBRAND DISEASE, British Journal of Haematology, 93, 1996, pp. 216-216
CRITICAL FUNCTIONAL REQUIREMENT FOR THE GUANIDIUM GROUP OF THE ARGININE RESIDUE-53 AND RESIDUE-91 OF VON-WILLEBRAND-FACTOR AS REVEALED BY SITE-DIRECTED MUTAGENESIS
Authors: JORIEUX S MAZURIER C
Citation: S. Jorieux et C. Mazurier, CRITICAL FUNCTIONAL REQUIREMENT FOR THE GUANIDIUM GROUP OF THE ARGININE RESIDUE-53 AND RESIDUE-91 OF VON-WILLEBRAND-FACTOR AS REVEALED BY SITE-DIRECTED MUTAGENESIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1169-1169
BIOLOGICAL EFFECT OF DESMOPRESSIN IN 8 PATIENTS WITH TYPE 2N (NORMANDY) VON-WILLEBRAND-DISEASE
Authors: MAZURIER C GAUCHER C JORIEUX S GOUDEMAND M DURIN A GOUAULTHEILMANN M GOUDEMAND J HANSS M PARQUETGERNEZ A PERNOD G SULTAN Y
Citation: C. Mazurier et al., BIOLOGICAL EFFECT OF DESMOPRESSIN IN 8 PATIENTS WITH TYPE 2N (NORMANDY) VON-WILLEBRAND-DISEASE, British Journal of Haematology, 88(4), 1994, pp. 849-854
FINE EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES TO THE NH2-TERMINAL PART OF VON-WILLEBRAND-FACTOR (VWF) BY USING RECOMBINANT AND SYNTHETIC PEPTIDES - INTEREST FOR THE LOCALIZATION OF THE FACTOR-VIII BINDING DOMAIN
Authors: JORIEUX S GAUCHER C PIETU G CHEREL G MEYER D MAZURIER C
Citation: S. Jorieux et al., FINE EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES TO THE NH2-TERMINAL PART OF VON-WILLEBRAND-FACTOR (VWF) BY USING RECOMBINANT AND SYNTHETIC PEPTIDES - INTEREST FOR THE LOCALIZATION OF THE FACTOR-VIII BINDING DOMAIN, British Journal of Haematology, 87(1), 1994, pp. 113-118
THE USE OF SITE-DIRECTED MUTAGENESIS OF VON-WILLEBRAND-FACTOR TO ELUCIDATE THE MECHANISM OF ITS INTERACTION WITH FACTOR-VIII
Authors: JORIEUX S HILBERT L MAZURIER C
Citation: S. Jorieux et al., THE USE OF SITE-DIRECTED MUTAGENESIS OF VON-WILLEBRAND-FACTOR TO ELUCIDATE THE MECHANISM OF ITS INTERACTION WITH FACTOR-VIII, Thrombosis and haemostasis, 69(6), 1993, pp. 558-558
Risultati: 1-14 |